Cellebrite (NASDAQ: CLBT) officer lines up 4,323-share sale
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) is the issuer of common stock that David Gee, identified as an officer, plans to sell under Rule 144. The notice covers a proposed sale of 4,323 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated aggregate market value of $47,769.15 as of August 24, 2026. The securities to be sold arise from Restricted Stock Units from the issuer. The filing also lists prior sales by David Gee over the past three months.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 4,323 shares
Aggregate market value of shares to be sold: $47,769.15
Shares sold on August 21, 2026: 2,198 shares
+3 more
6 metrics
Shares to be sold
4,323 shares
Common stock covered by the Form 144 notice
Aggregate market value of shares to be sold
$47,769.15
Value of 4,323 CLBT shares as listed for the planned sale
Shares sold on August 21, 2026
2,198 shares
Common stock sold by David Gee during the past 3 months
Proceeds on August 21, 2026 sale
$24,709.04
Value of 2,198 CLBT shares sold by David Gee
Shares sold on August 11, 2026
230 shares
Common stock sold by David Gee during the past 3 months
Proceeds on August 11, 2026 sale
$3,686.90
Value of 230 CLBT shares sold by David Gee
Key Terms
Form 144, Rule 144, Restricted Stock Units
3 terms
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Common | 08/20/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
What does the Form 144 filing for CLBT by David Gee disclose?
It discloses that David Gee, an officer of Cellebrite DI Ltd. (CLBT), has filed a Form 144 to sell 4,323 shares of the company’s common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.
What prior CLBT stock sales by David Gee are reported in the last 3 months?
The filing reports that David Gee sold 2,198 shares of CLBT common stock on August 21, 2026 for $24,709.04, and 230 shares on August 11, 2026 for $3,686.90, in the securities sold during the past 3 months section.
What type of securities is David Gee selling from Cellebrite DI Ltd. (CLBT)?
David Gee is selling common stock of Cellebrite DI Ltd. The securities to be sold are linked to Restricted Stock Units from the issuer, as specified in the securities-to-be-sold section of the Form 144 notice.
AI-generated analysis. How Rhea-AI works. Not financial advice.